Zimmer Biomet, Stryker, and B. Braun Melsungen AG are expected to Dominate the Global Knee Cartilage Repair market in 2021

Global Knee Cartilage Repair Market is expected to grow with the CAGR of 7.5% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-knee-cartilage-repair-market

Global knee cartilage repair market is highly consolidated and includes specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenario.

Major players operating in the global knee cartilage repair market are introducing a wide range of products and adopting strategic initiatives, such as acquisitions, agreements, business expansions, awards and recognitions, into the market. This helps companies to maximize their sales with enhanced product portfolio.

For instance:

  • In April 2021, Stryker partnered with Minor League Baseball and became the official SmartRobotics joint replacement partner. Stryker has launched the latest innovation in joint replacement technology, Mako SmartRobotics uses a 3D CT-Based planning software for hip and knee replacement. It helps the surgeons create a 3D image of each patient’s unique anatomy.

Zimmer Biomet is the dominating player in the global knee cartilage repair market. Other key players existing in the market are Smith+Nephew, Stryker, B. Braun Melsungen AG, The Future of Biotechnology, MEDIPOST, Vericel Corporation, CONMED Corporation, Medical Devices Business Services (DePuy Synthes), Meril Life Sciences Pvt. Ltd., Arthrex, Inc., Medacta International, Teijin Nakashima Medical Co., Ltd., BioTissue SA, ISTO Technologies, Inc., CartiHeal, Inc., Mathys AG Bettlach, Waldemar Link GmbH & Co.KG, JRI Orthopaedics, Regentis Biomaterials Ltd., Auxein Medical., EVOLUTIS INDIA PVT. LTD., and Japan MDM, Inc., among others.

Knee Cartilage Repair MarketZimmer Biomet

Zimmer Biomet is headquartered in Indiana, U.S. and established on 1927. The company is focused on providing innovative solutions that support orthopaedic surgeons and clinicians in alleviating pain and improving the quality of life for people around the world. The company operates its businesses via several business segments including knees, hips, surgical sports medicine, biologics, foot and ankle, extremities, dental spine & craniomaxillofacial and thoracic, and others in which surgical sports medicine is the market focused segment. The company has product categories including knees, hips, S.E.T., dental, spine and CMFT, and others in which S.E.T. is the market focused category.

For instance,

  • In April, Zimmer Biomet received Food and Drug Administration (FDA) clearance for JuggerStitch meniscal repair device. It is the next generation of the meniscus repair technology.

The company has wide presence across Americas, Asia-Pacific, Europe, and Middle East and Africa. The company also has various subsidiary companies including Accelero Health Partners, LLC (U.S.), Biomet International Orthopedics, LLC (Delaeare), Biomet Orthopaedics, LLC (Indiana), Cayenne Medical, Inc. (Delaware), and Dornoch Medical Systems, Inc. (U.S.) among others.

Stryker

Stryker was founded in the year 1941 and is headquartered in Michigan, the U.S. The main focus of the company is providing innovative products and services in Orthopedics, Medical and Surgical, Neuro technology, and spine that helps to improve patient and hospital outcomes. The company operates its business via several business segments including MedSurg, Orthopaedics, and Neurotechnology & Spine, in which Orthopedics is the market focused segment. The company has product categories, which are medical and surgical equipment, orthopedics, neurotechnology, services, and care settings in which orthopaedic is the market focused category.

For instance,

  • In April, Stryker partnered with Minor League Baseball and became the official SmartRobotics joint replacement partner. Stryker had launched the latest innovation in joint replacement technology, Mako SmartRobotics, which uses a 3D CT-Based planning software for hip and knee replacement. It helps surgeons to create a 3D image of each patient’s unique anatomy.

The company has presence across Asia-Pacific, Europe, Middle East and Africa, South America, and North America. It also has various subsidiaries including Stryker Australia LLC (Australia), Stryker Private Limited (India), Ross Creek Medical, Inc. (Delaware), Stryker Healthcare Products Co. Ltd. (China), Medicycle, Inc. (Arizona), and Stryker Trauma AG (Switzerland) among others.

B. Braun Melsungen AG

B. Braun Melsungen AG was founded in the year 1839 and is headquartered in Hessen, Germany. The company is focused on manufacturing and providing healthcare solutions, supplementary services, and consulting. It operates its businesses via several business segments including Hospital Care, Aesculap, OPM, B, Braun Avitum, and others in which Aesculap is the market focused segment. The company has one product category which is orthopaedic surgery.

The company has presence across Asia-Pacific, Europe, Middle East and Africa, South America, and North America. The company also has various subsidiaries including Aesculap AG (Germany), Aesculap Biologics, LLC (Germany), B. Braun India (India), B. Braun Medical S.A.S (France), and B. Braun Medical (Pty) Ltd. (South Africa) among others.